共 82 条
[1]
Miyakawa S(2009)Biliary tract cancer treatment: 5,548 results from the biliary tract cancer statistics registry from 1998 to 2004 in Japan J Hepatobiliary Pancreat Surg 16 1-7
[2]
Ishihara S(1999)Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer Oncology 56 177-180
[3]
Horiguchi A(2001)Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer Ann Oncol 12 183-186
[4]
Takada T(2003)A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas Chemotherapy 49 154-158
[5]
Miyazaki M(2006)Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Cancer Chemother Pharm 57 647-653
[6]
Nagakawa T(2013)Adjuvant surgery for advanced extrahepatic cholangiocarcinoma World J Gastroenterol 19 6934-6938
[7]
Raderer M(2013)Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study Ann Surg Oncol 20 318-324
[8]
Hejna MH(2010)Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 1273-1281
[9]
Valencak JB(2005)Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 1311-1319
[10]
Penz M(2009)Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies Am J Surg 197 752-758